Erik Dreaden, PhD, joined the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta and Emory University School of Medicine as Assistant Professor in August 2017 by way of the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology, where he was a Ruth L. Kirschstein Postdoctoral Fellow within the MIT Department of Chemical Engineering.
Dr. Dreaden earned his undergraduate degree in chemistry from the University of Georgia, followed by his PhD in chemistry and biochemistry from the Georgia Institute of Technology. While a fellow at MIT, he received the Koch Institute IMAGE Award two times.
Dr. Dreaden’s research interests include using molecular and nanometer-scale engineering to impart augmented, amplified and non-natural function to cancer therapies and immunotherapies.
As a native of Atlanta, Dr. Dreaden is immensely proud to be working alongside the patients, physicians and researchers here at Children’s, and he is hopeful that his research will directly lead to improvements in treatment outcomes for patients in our community and beyond.
When he’s not in the lab, you can find Dr. Dreaden jogging at Piedmont Park or rooting for the Atlanta Falcons and Atlanta Braves.